NCT00089687Unknown1 期
GBR 12909 Study in Cocaine Experienced African American Volunteers
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- pharmacokinetic assessment
研究概览
简要总结
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.
详细描述
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Must be within 20% of ideal body weight and must weigh at least 45 kg.
- •Must understand the study procedures and provide written informed consent.
- •Must meet DSM-4 criteria for abuse or dependence on cocaine.
- •Must be non-treatment seeking at the time of the study.
排除标准
- •Please contact the study site for more information.
结局指标
主要结局
pharmacokinetic assessment
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
1 期
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1Cocaine-Related DisordersNCT00051896National Institute on Drug Abuse (NIDA)24
Unknown
1 期
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1Cocaine-Related DisordersNCT00100113National Institute on Drug Abuse (NIDA)24
已完成
2 期
Cocaine Use Reduction With BuprenorphineCocaine DependenceNCT01402492University of California, Los Angeles302
已完成
2 期
Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)Cocaine-related DisorderNCT03242928Novartis Pharmaceuticals68
已完成
2 期
Bupropion-Enhanced Contingency Management (CM) for Cocaine DependenceSubstance AbuseCocaine DependenceNCT02111798Johns Hopkins University83